Efficacy and Safety of FDC in High Risk Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia (LANCE)
This study is not yet open for participant recruitment.
Verified August 2011 by Ache Laboratorios Farmaceuticos S.A.
Sponsor:
Ache Laboratorios Farmaceuticos S.A.
Information provided by (Responsible Party):
Ache Laboratorios Farmaceuticos S.A.
ClinicalTrials.gov Identifier:
NCT01420549
First received: August 18, 2011
Last updated: NA
Last verified: August 2011
History: No changes posted
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is not yet open for participant recruitment. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | October 2012 (Final data collection date for primary outcome measure) |